Paclitaxel-Carboplatin With The Oral Iap Inhibitor Debio1143 In A Subset Of Patients With Recurrent Epithelial Ovarian Cancer (EOC): Phase I

Presented at IGCS 2016, Lisbon, Portugal

I. Ray-Coquard (1), C. Le Tourneau (2), N. Isambert (3), C. A. Gomez-Roca (4), P. Cassier (1), M. P. Sablin (2), D. Purcea (5), E. Rouits (5), C. Schusterbauer (5), G. Vuagniaux (5), C. Zanna (5), P. Fumoleau (3), J. P. Delord (4).

1. Centre Léon Bérard, Lyon, France;
2. Institut Curie, Paris, France;
3. Centre Georges-François Leclerc, Dijon, France;
4. Centre Claudius Regaud, Toulouse, France;
5. Debiopharm International SA, Lausanne, Switzerland